announced-revised

Rare Cases of Liver Damage Tied to Weight-Loss Drug (HealthDay)

HealthDay – WEDNESDAY, May 26 (HealthDay News) — Responding to reports of rare but sometimes severe cases of liver damage, U.S. health officials on Wednesday announced revised labels for a widely used weight-loss drug.

Read the original post:
Rare Cases of Liver Damage Tied to Weight-Loss Drug
(HealthDay)

announced-revised

U.S. warns of liver risk with Glaxo, Roche diet drugs (Reuters)

Reuters – Weight-loss drugs from GlaxoSmithKline PLC and Roche Holding AG will carry new warnings about rare reports of liver injury, U.S. health officials said on Wednesday.

Here is the original post: 
U.S. warns of liver risk with Glaxo, Roche diet drugs
(Reuters)